YGL239C Antibody

What is YGL239C and what systems express this target?

YGL239C is a protein encoded by the YGL239C gene in Saccharomyces cerevisiae (Baker's yeast), specifically strain ATCC 204508/S288c. The antibody against this target is primarily reactive with this specific strain of Baker's yeast . The protein is part of the yeast genome that has been mapped through techniques such as saturated transposition . When designing experiments, researchers should consider that this antibody has been specifically raised against recombinant YGL239C protein from this particular strain.

What are the key specifications and handling requirements for YGL239C Antibody?

The YGL239C antibody (e.g., product code CSB-PA347379XA01SVG) is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae YGL239C protein. It is supplied in liquid form and contains preservatives (0.03% Proclin 300) in a storage buffer of 50% Glycerol and 0.01M PBS at pH 7.4 .

Storage and Stability Parameters:

The antibody is purified using antigen affinity methods and is intended strictly for research use only, not for diagnostic or therapeutic applications .

What validated applications exist for the YGL239C Antibody?

The YGL239C antibody has been validated for specific applications including ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) . When planning experiments, researchers should consider the following methodological aspects:

ELISA Applications:

• Use standard indirect ELISA protocols with appropriate blocking (typically 5% non-fat milk or BSA)

• For quantitative assays, establish a standard curve using purified recombinant YGL239C protein

• Consider sandwich ELISA if analyzing complex samples

Western Blot Applications:

• Use standard protein extraction protocols optimized for yeast cells

• Include denaturing agents appropriate for yeast membrane proteins

• Verify band specificity with positive and negative controls

• Typical dilutions range from 1:500 to 1:2000, but optimization is recommended

Similar to how antibodies like YYB-101 undergo validation for specificity and sensitivity in their target systems , proper validation steps should be performed for YGL239C antibody in your specific experimental setting.

How should sample preparation be optimized for YGL239C detection in yeast cells?

Efficient detection of YGL239C protein requires proper sample preparation techniques that preserve protein integrity while ensuring adequate extraction from yeast cells:

• Cell lysis optimization:

  • Mechanical disruption (glass beads, sonication) is often required for efficient yeast cell wall disruption

  • Buffer composition should include protease inhibitors to prevent target degradation

  • Consider detergent selection based on protein localization (cytosolic vs. membrane-associated)

• Protein extraction protocols:

  • For soluble proteins: Use non-ionic detergents (0.1-0.5% Triton X-100)

  • For membrane-associated proteins: Consider stronger detergents (CHAPS, SDS)

  • Optimize centrifugation speeds to separate cellular debris while retaining target protein

• Sample storage considerations:

  • Aliquot samples to avoid freeze-thaw cycles

  • Include reducing agents if disulfide bonds may affect epitope recognition

  • Document protein concentration determination methods for reproducibility

This methodological approach mirrors techniques used in other antibody validation studies, where sample preparation significantly impacts detection sensitivity .

How can YGL239C Antibody be incorporated into functional genomics studies?

The YGL239C antibody can serve as a valuable tool in functional genomics research, particularly when integrated with yeast genetic manipulation techniques:

• Protein-protein interaction studies:

  • Co-immunoprecipitation using YGL239C antibody can identify interaction partners

  • When combined with mass spectrometry, this approach can reveal protein complexes

  • Consider chemical crosslinking to stabilize transient interactions

• Integration with genomic screening data:

  • YGL239C has been identified in functional mapping studies of yeast genomes using saturated transposition approaches

  • The antibody can be used to validate findings from genetic screens through protein detection

  • Correlation between genetic data and protein expression patterns can provide functional insights

• Localization studies:

  • Immunofluorescence microscopy can reveal subcellular localization patterns

  • Comparing wild-type localization with mutant strains can provide functional insights

  • Multi-color imaging with markers for subcellular compartments can enhance localization precision

Similar integrated approaches have been used successfully with other antibodies in research settings to provide multidimensional data on protein function .

What controls and validation steps are critical for YGL239C Antibody experiments?

Rigorous experimental design requires appropriate controls and validation steps to ensure reliable and reproducible results:

• Essential experimental controls:

  • Positive control: Purified recombinant YGL239C protein or lysate from wild-type yeast

  • Negative control: Lysate from YGL239C knockout strain

  • Isotype control: Rabbit IgG at equivalent concentration to test for non-specific binding

  • Loading controls: Housekeeping proteins appropriate for yeast (e.g., actin, GAPDH)

• Antibody specificity validation:

  • Pre-absorption controls using purified antigen

  • Comparison of detection patterns in wild-type vs. knockout strains

  • Western blot analysis to confirm single band of expected molecular weight

  • Dot blot analysis with serial dilutions to establish detection limits

• Cross-reactivity assessment:

  • Testing against closely related yeast strains

  • Evaluation in systems where target protein is absent

  • Peptide competition assays to confirm epitope specificity

These validation approaches mirror those used in studies of therapeutic antibodies like YYB-101, where rigorous validation is essential for reliable interpretation of results .

What are common technical challenges when working with YGL239C Antibody and how can they be addressed?

Researchers may encounter several technical challenges when working with YGL239C antibody:

• Weak or absent signal issues:

  • Increase antibody concentration gradually (test dilution series)

  • Extend incubation times at optimal temperature

  • Enhance detection sensitivity through amplification systems

  • Verify target protein expression levels in your specific yeast strain

  • Consider epitope accessibility issues that may require alternative sample preparation

• High background problems:

  • Increase blocking stringency (5% BSA or milk, overnight at 4°C)

  • Add 0.1-0.3% Tween-20 to wash buffers

  • Reduce secondary antibody concentration

  • Pre-absorb antibody with yeast lysate lacking target protein

  • Consider using more specific detection systems

• Inconsistent results between experiments:

  • Standardize lysate preparation protocols

  • Maintain consistent antibody lot numbers when possible

  • Document all experimental parameters for reproducibility

  • Implement quantitative controls for normalization

These troubleshooting approaches are similar to those used in validation of other research antibodies, where systematic optimization is required for robust results .

How should data from YGL239C antibody experiments be quantified and statistically analyzed?

• Quantification approaches:

  • For Western blots: Densitometry using appropriate software with background subtraction

  • For ELISA: Standard curve fitting with appropriate regression models

  • For immunofluorescence: Fluorescence intensity measurement with cellular segmentation

• Normalization strategies:

  • Normalize to loading controls (total protein or housekeeping proteins)

  • Consider internal reference standards for inter-experimental comparisons

  • Document normalization approach thoroughly in methodological descriptions

• Statistical considerations:

  • Determine appropriate sample sizes through power analysis

  • Apply suitable statistical tests based on data distribution (parametric vs. non-parametric)

  • Account for multiple testing when analyzing complex datasets

  • Report both statistical significance and effect sizes

How can YGL239C antibody be used in conjunction with mutational analysis and functional screens?

The YGL239C antibody can be strategically integrated with genetic manipulation approaches:

• Validation of mutant phenotypes:

  • SATAY (Saturated Transposition Analysis in Yeast) and similar approaches have identified roles for various yeast genes including potential interactions involving YGL239C

  • The antibody can verify protein expression changes in mutant strains

  • Correlation between genetic perturbation and protein levels can establish causality

• Structure-function relationship studies:

  • Detection of truncated or modified proteins resulting from domain-specific mutations

  • Analysis of post-translational modifications affected by specific mutations

  • Verification of protein stability changes in response to genetic manipulation

• Screening support applications:

  • High-throughput validation of hits from genetic screens

  • Secondary screening to classify genetic hits based on protein expression patterns

  • Confirmation of gene knockout or silencing efficiency at the protein level

This integrated approach parallels successful strategies used in other biological systems, where antibody-based detection complements genetic analysis .

What considerations are important when designing experiments to study protein-protein interactions involving YGL239C?

When investigating protein interactions:

• Co-immunoprecipitation optimization:

  • Buffer conditions must balance interaction preservation with non-specific binding reduction

  • Crosslinking strategies may be necessary for transient interactions

  • Both forward and reverse co-IP can strengthen interaction evidence

  • Mass spectrometry analysis of immunoprecipitated complexes can identify novel interactors

• Proximity labeling approaches:

  • BioID or APEX2 fusion constructs with YGL239C can identify proximal proteins

  • The antibody can validate candidate interactions through conventional methods

  • Consider the impact of tags on protein function and localization

• Interaction visualization techniques:

  • Bimolecular fluorescence complementation with candidate interactors

  • Förster resonance energy transfer (FRET) analysis for direct interaction assessment

  • Co-localization studies using the antibody with fluorescently tagged candidate interactors

Similar methodological considerations have been crucial in studies of protein interactions in various biological systems, including those involving therapeutic antibodies like YYB-101 .